Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxinkang is a Traditional Chinese Medicine (TCM) herbal formulation developed and manufactured by Guangdong Xinbao Pharmaceutical. It is primarily indicated for the treatment of coronary heart disease and the relief of symptoms associated with angina pectoris. As a TCM product, it is designed to improve myocardial blood supply and reduce cardiac workload through the synergistic action of its herbal constituents, which typically focus on improving blood circulation and removing blood stasis. It is administered orally in tablet form and is currently approved and marketed in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guanxinkang.